Guidance

MenB vaccine and paracetamol

Information about the meningococcal B (MenB) vaccine and paracetamol use.

From:
UK Health Security Agency
Published
22 July 2015
Last updated
24 November 2022 — See all updates

Applies to England

Documents

Using paracetamol to prevent and treat fever after MenB vaccination

HTML

Using paracetamol to prevent and treat fever after MenB vaccination leaflet (print version)

Ref: UKHSA gateway number: 2018181

PDF, 159 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Information for healthcare professionals and parents on the increased risk of fever when the MenB vaccine is given alongside other immunisations at 2 and 4 months of age and the recommended use of prophylactic paracetamol.

Using paracetamol to prevent and treat fever after MenB vaccination

The advice on the use of paracetamol following MenB vaccination differs to previous advice on the use of paracetamol for post-vaccination fever which may still appear on infant paracetamol product packaging. In order to avoid confusion, a patient information leaflet has been produced detailing advice on paracetamol dosage and timings and addressing frequently asked questions. Every parent or guardian should be given a copy at the 2 month immunisation appointment.

Paper copies of this leaflet in English are available free to order.

Translated versions of this leaflet are available free to download in the following languages:

Albanian, Arabic, Bengali, Bulgarian, Chinese (simplified), Chinese (traditional, Cantonese), Estonian, Farsi, French, Greek, Gujarati, Hindi, Italian, Latvian, Lithuanian, Panjabi, Pashto, Polish, Portuguese, Romanian, Romany, Russian, Somali, Spanish, Tagalog, Tigrinya, Turkish, Twi, Ukrainian, Urdu, Yiddish and Yoruba.

MenB and paracetamol mock consultation

The UK Health Security Agency (UKHSA) has been working closely with Oxford Vaccine Group who have produced a mock video consultation including a discussion between a practice nurse and patient about the use of paracetamol following MenB vaccination. This is a key training resource for frontline immunisers to ensure that parents receive the necessary information on the increased risk of fever and correct use of paracetamol following the 2 and 4 month appointment visits. Local NHS England and UKHSA colleagues are requested to help to cascade this training locally to frontline immunisers.

MenB and Paracetamol consultation

Health publications orderline

Immunisation Publications
UK Health Security Agency, 61 Colindale Avenue, Colindale
London
NW9 5EQ

Contact form https://www.healthpubl...

Telephone: 0300 123 1002

Copies of printed publications and the full range of digital resources to support the immunisation programmes can now be ordered and downloaded online. Log in to register and place your order.

Published 22 July 2015
Last updated 24 November 2022 + show all updates

  1. Added links to translations.

  2. Removed 'Protocol for the supply or administration of paracetamol oral suspension 120mg/5mL to infants under 12 months of age receiving primary doses of MenB vaccination' as it has expired.

  3. Added 'Protocol for the supply or administration of paracetamol oral suspension 120mg/5mL to infants under 12 months of age receiving primary doses of MenB vaccination'.

  4. Update to 'Using paracetamol to prevent and treat fever after MenB vaccination' document with additional questions and answers.

  5. Added Oxford Vaccine Group mock video consultation on using paracetamol following MenB vaccination.

  6. Added MenB paracetamol protocol

  7. First published.

Related content